Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OPICAPONE vs ORITAVANCIN DIPHOSPHATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OPICAPONE vs ORITAVANCIN DIPHOSPHATE: Safety Overview

Metric OPICAPONE ORITAVANCIN DIPHOSPHATE
Total FAERS Reports 1,090 276
Deaths Reported 80 4
Death Rate 7.3% 1.4%
Hospitalizations 305 27
Average Patient Age 70.6 yrs 58.5 yrs
% Female Patients 42.2% 39.2%
FDA Approval Date Apr 24, 2020 Aug 6, 2014
Manufacturer Amneal Pharmaceuticals LLC Melinta Therapeutics, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription